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Abstract The study aimed at optimization of DNA iso-
lation from blood of representatives of four microbial
groups causing sepsis, i.e., Gram negative: Escherichia
coli, Gram positive: Staphylococcus aureus, yeast: Can-
dida albicans, and filamentous fungus: Aspergillus fumig-
atus. Additionally, the five commercial kits for microbial
DNA isolation from the blood were tested. The developed
procedure of DNA isolation consisted of three consecutive
steps, i.e., mechanical disruption, chemical lysis, and
thermal lysis. Afterward, DNA was isolated from the pre-
viously prepared samples (erythrocyte lysis) with the use of
five commercial kits for DNA isolation. They were com-
pared paying heed to detection limit, concentration, DNA
purity, and heme concentration in samples. The isolation of
DNA without preliminary erythrocyte lysis resulted in far
higher heme concentration than when lysis was applied. In
the variant with erythrocyte lysis, two of the commercial
kits were most effective in purifying the DNA extract from
heme. Designed procedure allowed obtaining microbial
DNA from all four groups of pathogens under study in the
amount sufficient to conduct the rtPCR reaction, which
aimed at detecting them in the blood.
Introduction
Effective diagnostic of factors causing the infection is the
most important, and most difficult, problem in the treat-
ment of blood infections. It is decisive as regards the
effectiveness of therapy and, consequently, the costs and
the duration of hospitalization. The identification of etio-
logical factors allows to employ efficient targeted antib-
iotherapy. The material submitted for the study is blood
taken from patients manifesting clinical symptoms of
sepsis. Until now, the so-called diagnostic ‘‘gold standard’’
has been constituted by blood cultures carried out on spe-
cial growth media, preferably in automated cell culture
systems. The advantages of such methods are their sim-
plicity and relatively low costs of testing. Their weakness
is that they are time-consuming, taking up to 5 days (until
the test results are issued), and have low detection limit,
which causes only 15–20 % of the culture to obtain
microbial growth [3].
In order to enhance the chances of identifying microbes
in blood, attempts are undertaken to identify them with the
help of nucleic acid detection. The difficulty lies in iso-
lating a proper quality of DNA matrix. It is necessary for it
to be of the highest possible concentration. Fungi and
different species of bacteria, which may be factors inducing
sepsis (sometimes polietiological), are characterized by
varied susceptibility to cell lysis and, consequently, the
possibility of obtaining DNA from them may also vary.
In scientific literature, there is a lack of a description of
a method for isolating DNA from blood which would be
effective in the case of both bacteria and fungi. Many
authors present methods which boil down to either isolat-
ing eukaryotic DNA from leukocytes or separately—from
bacteria or from fungi [1, 2, 8]. There have been ready-to-
use kits available on the market for several years now,
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e.g., Septifast (Roche) or Septitest (Molzym), serving the
purpose of detecting microbes in blood; however, the need
for working on new solutions is still in order [5, 10].
The objective of the study was to develop a compre-
hensive method for microbial (bacterial and fungal) DNA
isolation from blood to detect these pathogens and to
evaluate the usefulness of commercial kits for DNA
isolation.
Materials and Methods
Microbial Strains
Four strains were used in the research, these were repre-
senting groups diversified as regards the cell wall structure:
Gram-negative Escherichia coli ATCC 25922 (American
Type Culture Collection), Gram-positive Staphylococcus
aureus ATCC 33497, Candida albicans ATCC 10231
yeast, and Aspergillus fumigatus ATCC 14110 filamentous
fungus.
Blood Samples
Blood was collected from volunteers, who had no clinical
symptoms of sepsis and no inflammatory markers (CRP
and OB). Blood samples were drawn into 2-mL Vacutainer
K3E (Becton–Dickinson) test tubes. The research was
granted approval by the local Bioethics Committee of the
Jagiellonian University (KBET/94/B/2009).
The Method for Microbial DNA Isolation from Blood
DNA was isolated from 1.5-mL blood samples, which were
simultaneously inoculated with four model microbial
strains (E. coli, S. aureus, C. albicans, and A. fumigatus), in
order to obtain the cell number of 106 CFU/mL for each of
them. The number of the A. fumigatus conidia was deter-
mined by counting in a Bürker chamber.
The standardization of the method consisted in testing
different variants of preliminary blood samples processing:
(a) the samples were subjected to erythrocyte lysis in
0.17 M ammonium chloride solution (Sigma) (at the same
time, DNA was isolated to the exclusion of this stage, in
order to compare results); (b) mechanical disruption was
employed in the presence of glass beads / 710–1,180 lm
(Sigma) in a FastPrep machine (MP Biomedicals);
(c) enzymatic lysis of bacteria was conducted in the pre-
sence of the following enzymes: lysozyme (2 mg/mL),
lysostaphin (0.2 mg/mL), and lyticase 40 U (Sigma) at the
temperature of 37 C; and (d) the samples were subjected
to 50 mM NaOH (POCh) at 95 C.
In the next stage, DNA was isolated from the samples
using commercial kits for DNA isolation (following the
manufacturers’ protocols which included lysis of leuko-
cytes and proteins in the samples), in order to select the
optimal one: GeneMATRIX Quick Blood DNA Purifica-
tion Kit (EURx); GeneJET (Fermentas); QIAamp DNA
Blood (QIAGEN); Blood Mini (A&A Biotechnology); and
Genomic Mini (A&A Biotechnology). DNA was eluted
from the columns with the use of 100 lL Tris buffer. In the
case of each set, DNA was isolated from 16 samples.
DNA Amplification
All the processes of DNA amplification were performed
with the use of the real-time PCR method (rtPCR) in a
thermocycler CFX96 (BioRad) by employing species-spe-
cific primers and TaqMan probes. The sequences of oli-
gonucleotides utilized in the research and amplification
procedures are presented in Table 1.
Additionally, in every sample of DNA extract from
blood, b-actin gene detection was performed in order to
check whether rtPCR inhibition takes place; SYBRGreen
JumpStart Taq ReadyMix (Sigma) was used for that pur-
pose [9].
DNA Purity and Concentration
The concentration and purity of total DNA extract in the
samples were measured spectrophotometrically at wave-
lengths of A260 and A280. Heme concentration in the sam-
ples was measured at wavelength of A388 [4]. The
measurement was performed in DNA extracts obtained
from whole blood and subjected to preliminary processing.
It was performed in a NanoDrop machine (Thermo
Scientific).
The contents of microbial DNA in the samples were
determined with the help of the rtPCR method using spe-
cies-specific primers and TaqMan probes (Table 1).
Amplification mixture in 10 lL volume: 0.3 U Perpetual
Taq polymerase (EURx), 200 lM dNTP (EURx), 7.75 mM
magnesium chloride (EURx), 200 nM primer (F and R)
(Genomed), 300 nM probe (Genomed), and 3 lL DNA.
Amplification detection limit was defined as the relation of
the CT value, i.e., the number of reaction cycle in which the
linear increase of the product cuts an established baseline at
30 RFU.
Evaluation of the rtPCR Method Detection Limit
The evaluation of the PCR method detection limit con-
sisted in simultaneously inoculating the blood samples
taken from healthy volunteers with four reference strains
simultaneously (E. coli, S. aureus, C. albicans, and
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A. fumigatus), in the same blood sample, so as to obtain a
gradient of their number from 105 to 100 CFU/mL—the
number of the A. fumigatus conidia was determined by
counting in a Bürker chamber. Later, DNA was isolated
with the use of the prepared methodology and the chosen
kit for DNA isolation. The indication of detection limit was
performed for three different blood volumes, i.e., 1, 1.5,
and 5 mL. DNA was eluted from the columns with the
volumes of elution buffer presented in Table 2.
Subsequently, an amplification reaction was conducted
with species-specific primers and TaqMan probes
(Table 1). This was done individually for each microbe
species, in each of their blood dilutions, with the Perpetual
Taq polymerase (EURx). The procedure of amplification
consisted of 50 cycles (Table 1). Amplification mixture:
0.3 U Perpetual Taq polymerase (EURx), 200 lM dNTP
(EURx), 7.75 mM magnesium chloride (EURx), 200 nM
primer (F and R) (Genomed), and 300 nM probe (Gen-
omed). Volumes of DNA solutions (and whole reaction
volumes) used are presented in Table 2. DNA isolation and
PCR reactions were conducted in five repetitions. Ampli-
fication reaction detection limit was determined on the
Table 1 Oligonucleotide sequences employed in DNA amplification reactions of the four microbes
Microbe species 50–30 Amplification procedure
Gram (-) E. coli (F) GGGAGTAAAGTTAATACCTTTGC
(R) CTCAAGCTTGCCAGTATCAG
FAM-CGCGATCACTCCGTGCCAG
CAGCCGCGGATCGCG-BHQ1 [2]
95 C for 2 min (95 C for 15 s, 55 C
for 30 s, 72 C for 30 s) 50 cycles
Gram (?) S. aureus (F) TACATGTCGTTAAACCTGGTG
(R) TACAGTTGTACCGATGAATGG
(P) FAM-CGCGATCCAAGAACTTGTTGTTG
ATAAGAAGCAACCGATCGCG-BHQ1 [2]
95 C for 2 min (95 C for 15 s, 61 C
for 30 s, 72 C for 30 s) 50 cycles
C. albicans yeast (F) TTGGTGGAGTGATTTGTCTGCT
(R) TCTAAGGGCATCACAGACCTG
(P) FAM-TTAACCTACTAAATAGTGCTGCT
AGC-BHQ1 [8]
95 C for 2 min (95 C for 15 s, 55 C
for 30 s, 72 C for 30 s) 50 cycles
A. fumigatus filamentous
fungus
(F) TTGGTGGAGTGATTTGTCTGCT
(R) TCTAAGGGCATCACAGACCTG
(P) FAM-TCGGCCCTTAAATAGCCCGG
TCCGC-BHQ1 [8]
95 C for 2 min (95 C for 15 s, 61 C
for 30 s, 72 C for 30 s) 50 cycles
b-actin gene (F) GCCAGTGCCAGAAGAGCCAA
(R) TTAGGGTTGCCCATAACAGC [9]
95 C for 5 min (95 C for 30 s, 55 C
for 30 s, 72 Cfor 1 min) 30 cycles and
final extension at 72 C for 5 min
F forward primer, R reverse primer, P probe
Table 2 Volumes of DNA and
whole reaction solutions
The amplification procedure
involved 50 cycles
Volume of
Blood sample
volume (mL)
The final DNA
eluate (lL)
Amplification
reaction (lL)
Template
added (lL)
E. coli 1 200 10 3
S. aureus
C. albicans
A. fumigatus
E. coli 1.5 300 60 30
S. aureus
C. albicans
A. fumigatus
E. coli 5 200 10 3
S. aureus
C. albicans
A. fumigatus
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basis of the comparison of parameter CT value, i.e., the
consecutive reaction cycle number in which the linear
increase of the product cut the established baseline at
30 RFU.
Statistics
In the statistical analysis, Levene’s test was applied—in
order to confirm the equality of variances—followed by an
ANOVA test. Significant differences were established to be
of statistical significance of P \ 0.05. All calculations
were conducted using Gretl software ver. 1.9.4.
Results
Preliminary Processing of Blood Samples for Bacterial
and Fungal DNA Isolation
As a result of a series of experiments, the following blood-
processing procedure was formulated: 6 mL of 0.17 M
ammonium chloride (POCh) was added to 1.5 mL of whole
blood and incubated at 37 C for 20 min. Then, the sam-
ples were centrifuged at the speed of 10,000 rpm for
10 min and the supernatant was removed. The sediment
was suspended in a 100 lL solution of lysozyme (2 mg/
mL) (Sigma) and lysostaphin (0.2 mg/mL) (Sigma) in PBS
buffer. The whole mixture was transferred to test tubes
with glass beads 700–1,100 lm (Sigma) and subjected to
mechanical disintegration in FastPrep (MP Biomedicals)
machine for 20 s, at speed 4.0 m/s—the mixture was all
incubated for 30 min at 37 C. 200 lL 75 mM NaOH
(POCh) was added to the samples and incubated for 10 min
at 95 C. Next, it was centrifuged at speed 12,000 rpm for
10 min and the supernatant was discarded. 500 lL of
buffer consisting of 50 mM Tris–HCl pH 7.5 (Sigma),
10 mM EDTA (Sigma), 28 mM b-mercaptoethanol
(Sigma), and lyticase 40 U (Sigma) was added to the
sediment. The samples were incubated for 30 min at 37 C
and then centrifuged at 12,000 rpm for 10 min. The
obtained pellet was submitted to further processing with
the use of commercial kits for DNA isolation.
Evaluation of the Available Commerical Kits for DNA
Isolation
DNA was isolated from blood samples subjected to the
processing described above with the use of five commercial
kits according to the protocols provided by the manufac-
turers: GeneMATRIX Quick Blood DNA Purification Kit
(EURx); GeneJET (Fermentas); QIAamp DNA Blood
(QIAGEN); Blood Mini (A&A Biotechnology); and
Genomic Mini (A&A Biotechnology).
In the DNA extract obtained, the measurement of the
total concentration of DNA and its purity was performed.
The highest concentration of deoxyribonucleic acid was
found in the isolates obtained with Genomic Mini (A&A
Biotechnology) kit—31.99 ng/mL (Fig. 1). The highest
purity was noted in DNA extract from the Blood Mini
(A&A Biotechnology) set—1.95 ng/mL (Fig. 1). No sig-
nificant differences were demonstrated between the kits as
regards the measured purity and concentration of DNA.
Fig. 1 Comparison of kits for
isolating DNA from blood as
regards the obtained degree of
total DNA concentration and its
purity, with the application of
the developed preliminary blood
sample methodology
152 T. Gosiewski et al.: Isolation Microbial DNA from Blood
123
An evaluation of DNA concentration of the four repre-
sentatives of the studied microbial species was also per-
formed in the isolated samples. In the case of each set,
amplification signal was registered quickly in the DNA
samples isolated from blood subjected to preliminary pro-
cessing. Additionally, GeneMATRIX Quick Blood DNA
Purification Kit (EURx) proved to be the best, as the fol-
lowing results were recorded here: S. aureus (CT = 27.16),
E. coli (CT = 21.11), C. albicans (CT = 22.87), and A.
fumigatus (CT = 24.09) (Fig. 2a–d). The aforementioned
values were significantly different (P \ 0.001) from the
ones obtained with the use of the remaining kits as regards
each species. It is an indication that the use of preliminary
processing together with the GeneMATRIX Quick Blood
DNA Purification Kit (EURx) permits DNA amplification
signal to be received faster than from the remaining kits
under study.
A measurement of heme concentration was also per-
formed in the samples obtained from each of the studied
kits for DNA isolation, upon the use of preliminary pro-
cessing of blood samples or without it. The preliminary
procedure allowed the removal of substantially greater
(P \ 0.05) amount of heme than without its application in
all of the kits with the exception of QIAamp DNA Blood
(QIAGEN), where no significant difference was shown
(Fig. 3). The most effective sets as regards removing heme
from samples submitted to preliminary processing were:
GeneMATRIX Quick Blood DNA Purification Kit
(EURx)—2.76 lM and Blood Mini (A&A Biotechnol-
ogy)—2.73 lM, where the obtained results were signifi-
cantly (P \ 0.05) different from the remaining ones, while
no significant differences between those kits were shown
(Fig. 3). The method omitting preliminary processing did
not allow obtaining significant differences between the
studied commercial sets. The heme concentration in the
blood samples isolated directly with the use of commercial
kits yielded from 4.48 to 8.18 lM (Fig. 3).
Detection Limit of the Studied Microbes with the Use
of the rtPCR Method
The minimal limit number of studied microorganisms, the
presence of which could be detected in blood during the
performed rtPCR reaction, was defined as the method
Fig. 2 Comparison of DNA content of the microbes: a S. aureus,
b E. coli, c C. albicans, and d A. fumigatus in DNA samples isolated
from blood with the application of the elaborated preliminary
processing method for blood samples and the studied DNA isolation
kits. Asterisk values significantly different from the remaining ones
for a given microbe (P \ 0.001)
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detection limit. A positive result of the amplification
reaction indicated that the fluorescence intensity of the
PCR product was higher than the one determined for the
baseline, at 30 RFU. As regards the DNA samples isolated
from 1 to 5 mL of blood, the boundary detection signal for
microbial DNA remained at the same level: E coli—
3.0 9 101 CFU/mL, S. aureus—3.0 9 103 CFU/mL,
C. albicans—3.0 9 104 CFU/mL, and A. fumigatus
3.0 9 103 CFU/mL. Isolation from 1.5 mL of blood and
the increased volume of elution and DNA content in the
reaction mixture allowed raising the determination detec-
tion limit per one order of magnitude for A. fumigatus
(3.0 9 102 CFU/mL) and E. coli (3.0 9 100 CFU/mL) and
two orders of magnitude for S. aureus (3.0 9 101 CFU/
mL) and C. albicans (3.0 9 102 CFU/mL). The determi-
nation was conducted five times and the result was con-
sidered significant if the detection signal was received in at
least three repetitions.
Discussion
Detection of microorganisms in blood with the use of the
PCR method requires prior isolation of their DNA. Isola-
tion of DNA from leukocytes does not present difficulties
as white blood cells are surrounded only by a thin cell
membrane. The microbial cell structure brings about the
necessity to apply additional processes which could allow
digesting their cell walls (e.g., enzymatic lysis) in order to
gain access to nucleic acids. The matters get complicated
even further because of the fact that blood may contain
microorganisms of various cell wall structures, i.e., not
only Gram-positive and Gram-negative bacteria, but also
yeast or filamentous fungi. Consequently, it is necessary to
compile several processes, enabling obtaining high-quality
DNA matrix, in order to develop an efficient method for
microbial DNA isolation from blood.
In scientific literature, methods for bacterial and fungal
DNA isolation from blood are described, but they are
enabling one to separately isolate either bacterial or fungal
DNA from blood [1, 2, 6, 8, 12].
Also ready-to-use brand name kits for isolating DNA
from blood are designed to obtain deoxyribonucleic acid
from either only blood or, upon the introduction of an
additional stage, from bacteria or from fungi, e.g., QIAamp
DNA Blood (QIAGEN) or Blood Mini (A&A Biotech-
nology). On the market, there are several ready-to-use kits
for microbial, both bacterial and fungal, DNA detection
from blood, such as Septifast (Roche) or Septitest (Mol-
zym), which enable complex DNA isolation. Yet, there still
exists a need for devising new methods of efficient diag-
nostics of molecular sepsis.
In the present study, a method has been suggested which
enables simultaneous DNA isolation of a Gram-negative
bacterium E. coli ATCC 25922, a Gram-positive one S.
aureus ATCC 33497, C. albicans ATCC 10231 yeast, and
a filamentous fungus A. fumigatus ATCC 14110 from
blood. The four species represent groups of microorgan-
isms which are varied as regards their cell wall structure
and can cause sepsis. The developed procedure consisted of
three consecutive steps, i.e., mechanical disruption,
chemical lysis, and thermal lysis. Afterward, DNA was
isolated from the previously prepared samples with the use
of several commercial kits for DNA isolation. As was
demonstrated in this study, such a procedure allowed
obtaining DNA from all four microorganisms under study
in the amount sufficient to conduct the rtPCR reaction,
which aimed at detecting them in blood. As shown, the
Fig. 3 Comparison of the
degree of heme concentration in
DNA extract obtained with the
use of DNA isolation kits both
when the developed preliminary
blood sample processing was
applied and without it. Asterisk
the significantly different results
of heme concentration
comparison within one DNA
isolation kit when applying
preliminary blood samples
processing and without it; Hash
results received by applying
preliminary blood samples
processing significantly
different from the remaining
kits under study (P \ 0.05)
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lowest sensitivity demonstrated for A. fumigatus cells what
is associated with composition of its cell wall which is
thicker than bacterial cell wall. The GeneMatrix Quick
Blood DNA Purification Kit (EURx) proved to be signifi-
cantly better than the others (Fig. 2a–d). Other authors
conducted comparative studies for microbial DNA isola-
tion kits, but they concerned either only bacteria in blood
or fungi suspended in an appropriate buffer [6, 7]. The
results obtained by them concerned different volumes of
blood samples and various isolation kits; moreover, no
preliminary processing procedure was applied, so there is
no possibility of comparing the results with ours.
The elaborated methodology was also evaluated in terms
of the detection limit of E. coli, S. aureus, C. albicans, and
A. fumigatus depending on the volume of blood samples
utilized for DNA isolation. The analysis of the received
results permitted to conclude that there is no difference in
the detection limit of the method in the case of DNA iso-
lation in 1 and 5 mL volumes; however, the detection limit
for E. coli, S. aureus, C. albicans, and A. fumigates could be
increased by isolating DNA from 1.5 mL of blood and uti-
lizing DNA matrix in the process of amplification in the
volume of 30 lL by the mixture volume of 60 lL. This
effect is presumably a result of the use of a much larger
DNA volume for amplification, which increased the prob-
ability of a sequence of microorganism species to appear in a
sample in the event of their limit number. The determined
method detection limit for detection of the four species
allowed to distinguish the number of microbial cells in
blood in the quantity of: 3 CFU/mL for E. coli and 30 CFU/
mL for S. aureus, whereas the yeast and the filamentous
fungus were characterized by the level of 300 CFU/mL. The
obtained results differ from the ones received with the use of
SeptiFast (Roche) kit, where they amounted to 3 CFU/mL
for E. coli, 30 CFU/mL for S. aureus, 30 CFU/mL for C.
albicans, and 3 CFU/mL for A. fumigatus [11]. In the case
of the fungi, the detection limit determined in this paper is
lower, which can be explained by the fact that the method-
ology presented here assumed the use of 30 lL of DNA as
matrix for amplification; while in the case of SeptiFast
(Roche) kit, 50 lL was used. The detection limit of detec-
tion for both species of bacteria was identical, which prob-
ably is connected to the fact that their cell wall gives into
lysis much more easily; therefore, it is possible to get more
DNA from the same number of cells in comparison to fungi.
Molecular diagnostic of sepsis is a very hard task. It is
still the case that blood culture remains the basic diagnostic
method, although theoretically there exists technical
potential to detect microbes with the use of molecular
methods. The difficulties described in this study delimit the
direction of essential research, which has to be carried out
in order to draw up an efficient and complex method for
microbial DNA isolation from the blood.
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